PROVIDER PROFILE · NPI 1780630954
Paul Demarco
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
25
Beneficiaries
—
Total drug cost
$397
Distinct drugs
2
Brand share
0.0%
Top prescribed drugs
Meloxicam13 claims
Hydroxychloroquine Sulfate12 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$166
Payment records
3
By payment type
Food and Beverage$166
Top paying entities
Food and Beverage$166
REFERRAL NETWORK
Where Paul Demarco's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Incorporated Md Clinical Laboratory · Baltimore, MD | 48 | 90 |
| Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ | 27 | 79 |
| MONTGOMERY GENERAL HOSPITAL, INC. | 13 | 28 |
| Alan Matsumoto Rheumatology · Wheaton, MD | 12 | 33 |
| SUBURBAN HOSPITAL, INC. | 12 | 31 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE